Pheon Therapeutics
Biotechnology Research • 
Harpenden, England, United Kingdom • 21-50 Employees
Company overview
| Headquarters | Lawes Open Innovation Hub, Rothamsted Research, London, England AL5 2JQ, GB |
| Website | |
| NAICS | 541714 |
| Founded | 2022 |
| Employees | 21-50 |
| Socials |
Key Contacts at Pheon Therapeutics
George Procopiou
Director Of Chemistry
Myles Clancy
Executive Director, Clinical Development
Sean Spring
Associate Director- Downstream Process Development
Lawrence Cripe
Executive Director, Business Development & Corporate Strategy
Brendan Nicholas
Senior Director, Finance
Paul Jackson
Co-Founder
Alexandra Vogel
Associate Director, Clinical Trial Lead
Cuihua Zhu
Associate Director, Upstream Process Development, Manufacture Production
Cuihua Zhu
Associate Director
Pheon Therapeutics Email Formats
Pheon Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@pheontx.com), used 88.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@pheontx.com | 88.9% |
{first initial}.{last name} | j.doe@pheontx.com | 11.1% |
About Pheon Therapeutics
Pheon Therapeutics is leveraging two decades of ADC experience to build a novel pipeline of next generation ADCs which offer the potential to treat solid tumors and liquid cancers that do not respond to other treatments. Understanding there is no “one size fits all” in engineering ADCs, Pheon takes a methodical approach to ADC development. Using both novel and clinically validated monoclonal antibodies (mAbs) and arming them either with warheads from their proprietary payload platform which boasts a novel mechanism of action or with off-the-shelf linker payload combinations, Pheon is finely attuned to balancing safety and efficacy for each target. Pheon’s lead program exploits a novel target that is highly expressed in a broad range of solid tumors. The lead agent is expected to reach IND within the next 18 months. Backed by expert, specialist healthcare investors Atlas Venture, Brandon Capital, Forbion and Research Corporation Technologies, Pheon Therapeutics has a world class, proven leadership team that brings together the best of ADC engineering, clinical strategy and business expertise. The company has state-of-the-art medicinal chemistry laboratories in London (United Kingdom), and a commercial office in Boston (United States).
Pheon Therapeutics revenue & valuation
| Annual revenue | $1,000,000 |
| Revenue per employee | $35,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,200,000 |
| Total funding | $188,000,000 |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
Pheon Therapeutics has 14 employees across 7 departments.
Departments
Number of employees
Funding Data
Explore Pheon Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Pheon Therapeutics Tech Stack
Discover the technologies and tools that power Pheon Therapeutics's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Hosting
JavaScript libraries
Miscellaneous
Programming languages
Blogs
Maps
Databases
Miscellaneous
Performance
Documentation
JavaScript libraries
India
United Arab Emirates
Netherlands
Frequently asked questions
4.8
40,000 users
